CGRP Forum

CGRP Forum is an expert resource for clinicians and healthcare professionals working with migraine patients.

[CGRP Forum @cgrpforum]

Real-world research suggests a promising new approach for treating #chronicmigraine. A small study found triple therapy significantly reduced #migraine frequency and improved disability over 12 months. More on @cgrpforum >> https://t.co/xFlhspvhjS
#Neurology #CGRP #Headache #HCPs

[CGRP Forum @cgrpforum]

Stay up to date with advancing #migraine science. Join @cgrpforum today for FREE access to expert insights, cutting-edge research, clinical updates and congress highlights: https://t.co/0fBp4kSeqF
#CGRP #Neurology #MigraineResearch #HeadacheMedicine #neuroTwitter #migraineTwitter

[CGRP Forum @cgrpforum]

Some people with #migraine can stop preventive anti-CGRP therapy without losing its benefits—but who are they? New research from Japan, presented at #EAN2026, identifies predictors of these ‘treatment graduates’. Learn more on @cgrpforum >>
https://t.co/2rlrKZOKhA

#NeuroTwitter

[CGRP Forum @cgrpforum]

New real-world research suggests a promising new approach for treating #chronicmigraine. A small study presented at #EAN2026 found triple therapy significantly reduced #migraine frequency and improved disability over 12 months. Read more on @cgrpforum >> https://t.co/xFlhspvhjS

[CGRP Forum @cgrpforum]

New from #EAN2026: Patients with #migraine are more likely to stay on CGRP-targeting preventive treatment than older therapies, according to new data in adults and adolescents. Read more on @cgrpforum: https://t.co/Ao2tfhviIf

#CGRP #neurology #neuroTwitter @EANeurology

[CGRP Forum @cgrpforum]

News from #EAN2026: encouraging #CGRP research on treatment persistence in adults & adolescents, triple therapy for difficult-to-treat chronic #migraine, premonitory symptoms, and who may safely stop CGRP mAb therapy. Read more on @cgrpforum: https://t.co/x16O6thn2f
@EANeurology

[CGRP Forum @cgrpforum]

Our #AHSAM 2026 coverage highlights promising data on investigational therapies targeting #PACAP and the migraine-associated ion channel #TRPM8. Stay up to date with the latest #migraine research on @cgrpforum >> https://t.co/W4MeGdoDwE

#neurologists #pharmacists @ahsheadache

[CGRP Forum @cgrpforum]

A new study presented at #AHSAM 2026 shows that only 1 in 5 gepant prescriptions are issued by #primarycare physicians despite the fact they see the majority of patients with #migraine.

Read more on #CGRP Forum >> https://t.co/HHbUpz0EWq
#neurologists #pharmacists #nurses

[CGRP Forum @cgrpforum]

Symptom freedom remains a major challenge in #chronicmigraine. Phase 3 UNCHAINED data presented at #AHSAM 2026 suggest combining anti-CGRP and #botulinumtoxin therapies may help patients achieve more completely symptom-free days. Read more: https://t.co/ViVeN97T12

#CGRP #gepants

[CGRP Forum @cgrpforum]

#BrainFog affects up to 90% of people during a #migraine. A real-world study presented at #AHSAM showed over half of patients taking #antiCGRPtherapy saw improvements in cognitive symptoms—starting in just 7 days and lasting at least 12 months. Read more: https://t.co/0rifucQKsS

[CGRP Forum @cgrpforum]

Lots of positive news for #migraine care at #AHSAM 2026: anti-CGRP therapies showed benefits for cognitive symptoms, combination approaches gained support, and novel treatments targeting emerging migraine mechanisms delivered promising results. Read more: https://t.co/W4MeGdoDwE

[CGRP Forum @cgrpforum]

Effective treatment for #clusterheadache is limited, but data from a study of the anti-CGRP therapy, #rimegepant showing improvement in headache frequency and severity are encouraging. Find out more on @cgrpforum > https://t.co/a3KeOPhQPm

#CGRP #AANAM @MayoClinic #neuroTwitter

[CGRP Forum @cgrpforum]

Get up to date with latest results of studies with anti-CGRP therapy in children and adolescents with episodic and #chronicmigraine in our report from #AANAM 2026 on @cgrpforum >> https://t.co/BpqccGC2Hv

#CGRP #fremanezumab #migraine #paediatricneurologists #neuroTwitter

[CGRP Forum @cgrpforum]

As #IIH diagnoses rise, new data presented at #AANAM 2026 suggest #CGRP may play a role in the #migraine-like headaches linked to the condition—raising the possibility that anti-CGRP therapies could help. Read more on @cgrpforum: https://t.co/91sTKXSzL7
#neuroTwitter #Neurology

[CGRP Forum @cgrpforum]

Early-phase data presented at #AANAM 2026 suggest co-administering a novel anti-PACAP antibody with an approved #gepant for acute #migraine is well tolerated, with no adverse pharmacokinetic interactions reported. Read more >> https://t.co/4c2bQmrdDQ

#CGRP #neurologists #PACAP

[CGRP Forum @cgrpforum]

Some patients using #antiCGRP therapies to prevent #migraine see increased blood pressure. But intriguing research presented at #AANAM 2026 suggests that much depends on whether they had #hypertension before starting treatment.
Read more on @cgrpforum … https://t.co/TdoW1R6vzj

[CGRP Forum @cgrpforum]

For patients with #migraine who are #overweight or #obese, #atogepant 60mg shows dual benefit—reducing monthly migraine days and body weight. Data from Phase 3 ELEVATE & PROGRESS trials, presented at #AANAM 2026 and reported on @cgrpforum.

https://t.co/Oq5NNhLlxV

#weightloss

[CGRP Forum @cgrpforum]

See highlights from #AANAM 2026 presentations of latest advances in #migraine prevention and treatment with #antiCGRP therapies, including weight loss effects, paediatric & cluster headache data and a new PACAP-targeting agent, on @cgrpforum >https://t.co/252woOGvpI
#neuroTwitter

[CGRP Forum @cgrpforum]

1/10 children & teens experience #migraine, yet only one anti-CGRP therapy is approved for them. A small study of off-label #rimegepant in under-18s shows promising pain relief—but needs clinical trial confirmation. Read more: https://t.co/jgqRnOAwS2
@ihs_official @NatMigraineCtr

[CGRP Forum @cgrpforum]

The American Headache Society has proposed annual #migraine screening for women as part of their preventive healthcare services. Annual screening is simple, scalable, and evidence based. Read more on @cgrpforum >> https://t.co/LdHRVXDyHl
@ahsheadache #headache